SE408172B - Sett att framstella kristallint l-pyroglutamyl-l-histidyl-l-prolinamidtartrat - Google Patents

Sett att framstella kristallint l-pyroglutamyl-l-histidyl-l-prolinamidtartrat

Info

Publication number
SE408172B
SE408172B SE7408649A SE7408649A SE408172B SE 408172 B SE408172 B SE 408172B SE 7408649 A SE7408649 A SE 7408649A SE 7408649 A SE7408649 A SE 7408649A SE 408172 B SE408172 B SE 408172B
Authority
SE
Sweden
Prior art keywords
prolinamid
crystally
manufactureing
pyroglutamyl
histidyl
Prior art date
Application number
SE7408649A
Other languages
English (en)
Swedish (sv)
Other versions
SE7408649L (xx
Inventor
M Fujino
C Hatanaka
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE7408649L publication Critical patent/SE7408649L/
Publication of SE408172B publication Critical patent/SE408172B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7408649A 1973-07-02 1974-07-01 Sett att framstella kristallint l-pyroglutamyl-l-histidyl-l-prolinamidtartrat SE408172B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP48074973A JPS528375B2 (xx) 1973-07-02 1973-07-02

Publications (2)

Publication Number Publication Date
SE7408649L SE7408649L (xx) 1975-01-03
SE408172B true SE408172B (sv) 1979-05-21

Family

ID=13562732

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7408649A SE408172B (sv) 1973-07-02 1974-07-01 Sett att framstella kristallint l-pyroglutamyl-l-histidyl-l-prolinamidtartrat

Country Status (14)

Country Link
US (1) US3959247A (xx)
JP (1) JPS528375B2 (xx)
BE (1) BE817058A (xx)
CA (1) CA1025852A (xx)
CH (1) CH602600A5 (xx)
DE (1) DE2431331C2 (xx)
DK (1) DK147852C (xx)
FR (1) FR2235914B1 (xx)
GB (1) GB1466390A (xx)
HK (1) HK980A (xx)
MY (1) MY8000232A (xx)
NL (1) NL178323C (xx)
SE (1) SE408172B (xx)
ZA (1) ZA744099B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions
JP2653255B2 (ja) 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
CA2050425A1 (en) 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
NZ240214A (en) 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
ATE161716T1 (de) 1992-08-07 1998-01-15 Takeda Chemical Industries Ltd Herstellung von mikrokapseln, die wasserlösliche arzneimittel enthalten
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
EP0813887A3 (en) * 1996-06-20 1999-11-03 Hisamitsu Pharmaceutical Co. Inc. A device structure for iontophoresis
CA2430934C (en) 2000-12-01 2011-06-21 Takeda Chemical Industries, Ltd. A method of producing sustained-release preparations of a bioactive substance using high-pressure gas
US20040028613A1 (en) * 2001-06-25 2004-02-12 Nastech Pharmaceutical Company Inc Dopamine agonist formulations for enhanced central nervous system delivery
GB0326632D0 (en) 2003-11-14 2003-12-17 Jagotec Ag Dry powder formulations
EP2611416B1 (en) 2010-09-03 2015-08-19 Pharmaterials Ltd. Pharmaceutical composition suitable for use in a dry powder inhaler
JP6224586B2 (ja) 2012-07-10 2017-11-01 武田薬品工業株式会社 注射用製剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795516A (fr) * 1972-02-17 1973-08-16 Ciba Geigy Preparations de peptides huileuses et injectables et procede pour leur preparation

Also Published As

Publication number Publication date
AU7060274A (en) 1976-01-08
DE2431331C2 (de) 1982-07-01
CH602600A5 (xx) 1978-07-31
FR2235914B1 (xx) 1976-10-08
US3959247A (en) 1976-05-25
HK980A (en) 1980-01-18
CA1025852A (en) 1978-02-07
NL178323C (nl) 1986-03-03
DE2431331A1 (de) 1975-05-22
SE7408649L (xx) 1975-01-03
FR2235914A1 (xx) 1975-01-31
MY8000232A (en) 1980-12-31
JPS50121273A (xx) 1975-09-23
DK147852C (da) 1985-06-03
JPS528375B2 (xx) 1977-03-09
DK355974A (xx) 1975-02-24
BE817058A (fr) 1974-12-30
NL7408881A (nl) 1975-01-06
ZA744099B (en) 1975-06-25
GB1466390A (en) 1977-03-09
NL178323B (nl) 1985-10-01
DK147852B (da) 1984-12-24

Similar Documents

Publication Publication Date Title
SE408712B (sv) Sett att framstelladubbelsalter av s-adenosyl-l-metionin
SE404804B (sv) Sett att framstella 18-metyl-19-nor-20-ketopregnaner
SE7408486L (sv) Sett att framstella poperazinyl-kinoxalinforeningar.
BG20566A3 (bg) Метод за получаване на 1-арилокси-2-хидрокси-3-алкиниламиниопропани
SE408172B (sv) Sett att framstella kristallint l-pyroglutamyl-l-histidyl-l-prolinamidtartrat
TR18209A (tr) Malelik anhidrit imaline mahsus usul
SE403478B (sv) Sett att framstella 2,2,6,6-tetrametyl-4-oxopiperidin
SE410607B (sv) Sett att framstella pregnan-21-syraderivat
SE406327B (sv) Sett att framstella d-homo-1,4-pregnadien-3,20-dioner
SE407939B (sv) Sett att framstella 7-fluorsubstituerade fentiaziner med forlengd neurolopetisk effekt
SE405254B (sv) Sett att framstella 7-hydroxi-ostratriener
SE409472B (sv) Sett att framstella kornorienterad kiselstralplat
IT1023218B (it) Procedimento per produrre idrocar buri
SE403373B (sv) Sett att framstella aminosubstituerade tetracykliska foreningar
SE401187B (sv) Sett att framstella deltaŸ4-3-ketosteroid-17-propiolakton
SE397190B (sv) Sett att framstella substituerade dibensocykloheptener
FI55498B (fi) Foerfarande foer framstaellning av hypoglycemiska pyridinkarboxamid-sulfonylureafoereningar
SE387111B (sv) Sett att framstella bensoylfenylguanidiner
SE402583B (sv) Sett att framstella alfa-etinylbenshydrol
SE404192B (sv) Sett att framstella 3 beta-cykloalkyloxi-16 alfa-cyanopregn-5-en-20-oner
SE411342B (sv) Sett att framstella 4-acetamido-fenyl-3-acetoxibensoat
SE396219B (sv) Sett att framstella pyridyl-piperazinderivat
SE396751B (sv) Sett att framstella s?72iv-benso-1,2,4-tiadiaziner
SE399265B (sv) Sett att framstella bensotiopyranoindazol-n-oxider
SE385012B (sv) Sett att framstella 4,9,11 - trien-steroid-derivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7408649-7

Effective date: 19940810

Format of ref document f/p: F